Purpose: To determine differences in key tear film cytokines between mild and severe cases of acanthamoeba keratitis (AK) and control contact lens (CL) wearers.
A canthamoeba keratitis (AK) is one of the most severe forms of corneal infection, with over 90% of cases occurring in contact lens (CL) wearers. 1 Vision loss occurs in 33% of patients, with corneal transplantation required in around 26%. 2 Recent reports, and case monitoring at our center, show that the numbers of AK cases are increasing. 3, 4 AK generally affects a young and otherwise healthy group of individuals 5 in whom lifetime disability costs are high. Apart from the long-term effects, such as decreased quality of life, and loss of productivity due to reduced vision, there are significant short-term costs to patients and carers, such as loss of wages and distress, in addition to symptoms such as severe pain and light sensitivity experienced by patients. 6 Some complications associated with CLs are somewhat controlled by the release of tear inflammatory molecules, such as in giant papillary conjunctivitis, which is characterized by altered levels of eotaxin, 7 or corneal neovascularization, which is mediated by vascular endothelial growth factor. 8 Moreover, it has been shown that CL wearers with CLinduced acute red eye present higher concentrations of interleukin (IL)-8 than that of healthy subjects. 9 Others [10] [11] [12] [13] have indicated altered levels of tear cytokines such as IL-6, IL-8, and epidermal growth factors during CL wear. However, to date, little is known about the tear inflammatory mediation in AK. Profiling patients with AK during disease could show differences in cytokine levels between severe and milder disease that may inform clinical management.
The aim of this study was to determine the differences in cytokine levels in patients wearing CLs with AK compared with CL wearers without the disease. A secondary goal is to investigate differences in cytokine levels between patients with severe forms of AK and those with mild-moderate forms of this infection.
control CL wearers from the Institute of Optometry, London. The research protocol adhered to the tenets of the Declaration of Helsinki and was approved by the local ethics committee. Written informed consent was obtained from all participants.
Participants
Severe cases of AK were defined as having active infection for over 12 months and having had at least 1 severe inflammatory event such as scleritis, persistent nonhealing defect (for 14 days or more), and/or pupil paralysis. Mildmoderate cases had recurrent disease in the absence of severe inflammatory events or disease that required active treatment for less than and up to 12 months.
Tear Sample Collection
Samples were collected from patients with AK at follow-up visits during their treatment on a convenience basis, depending on the flow of the clinic visits. Collection times varied between 10 AM and 4 PM. Samples were collected only from the affected eye. In bilateral cases, the worst affected eye was sampled.
Samples were collected from control CL wearers at the conclusion of routine aftercare appointments at the Institute of Optometry. Lenses may or may not have been worn according to the patient preference at the end of the appointment. So as to not affect the equilibrated tear milieu, that status remained for tear collection. For these control CL wearers, samples were collected from the right eye, and switched to the left should no sample be obtained from the right eye. In monocular wearers, the eye sampled was the CLwearing eye.
Tear samples for both AK cases and controls were basal tear specimens collected by 10-mL capillary tubes (BLAU-BRAND intraMark, Wertheim, Germany) and stored in EDTA-coated 0.5-mL Eppendorf Tubes. After collection, the samples were kept cold using a standard cool box and ice packs. On delivery to the laboratory on the same day, the samples were centrifuged at 1,600 rpm for 5 minutes. The cell-free supernatant was then pipetted into clean EDTAcoated 0.5-mL Eppendorf Tubes and stored at 280°C before analysis.
Analysis of Tear Molecules
Cytokines IL-1b, IL-6, IL-8, IL-10, IL-17A, IL-17E, IL-17F, IL-22, interferon gamma (IFNg), and chemokine (C-X-C motif) ligand 2 (CXCL2) were chosen for analysis based on established and hypothesized inflammatory pathways in AK. Tear protein levels were measured with a multiplex bead array using the Luminex-based platform (Luminex 100; Luminex Corporation, Austin, TX) for all analytes apart from CXCL2. CXCL2 was measured with an enzyme-linked immunosorbent assay (ELISA; Abcam, Cambridge, United Kingdom), as this protein was not compatible with the chosen Luminex range of targets.
Samples were diluted with the respective kit reagent depending on the sample volume and normalized for analysis.
Standard curves using duplicate known dilutions were generated for the Luminex and ELISA analysis. Luminex data were analyzed with instrument software, and raw scores of the ELISA optical density were converted to concentrations in Excel 2010 (Microsoft). Concentrations lower than the detectable limits were labeled as not detectable. Final concentrations above the minimum detectable limit were adjusted for the dilution factor.
Data Analysis
Statistics were analyzed using Graphpad.com/online calculator and Microsoft Excel 2010 software.Differences between cases and controls and between severe and mildmoderate cases were determined as follows: the Fisher exact test was performed to determine the proportions of detectable samples and the Mann-Whitney U test was used for the sample quantities over the detectable levels. P # 0.05 was considered statistically significant.
RESULTS
One hundred and thirty-two tear samples were collected from a total of 61 AK cases (15 severe and 46 mildmoderate) and 22 controls. There were no differences in sex distribution between case and control groups (P = 0.06); however, significant differences in age were found between the groups (P , 0.001). In addition, there were more wearers of daily disposable CLs in the control group than in AK cases (P = 0.02). Descriptive data detailing age, sex, and lens type are shown in Table 1 .
Levels of IL-6, IL-8, IL-22, and IL-17E were readily detectable. The levels of IFNg, IL-17F, IL-17A, IL-10, IL-27, and IL-1b were below the minimum detectable limit for all case and control samples. The proportion of nondetectable samples for each protein is detailed in Table 2 .
Cases Versus Controls Figure 1 shows the proportion of cytokines for the cases and controls for each of the molecules for which there was more than 1 positive sample (IL-1b was detectable in only 1 sample and was considered "nondetectable" for this study). There were more samples with detectable levels of IL-8 in the cases than in controls (P = 0.003). Almost half of the tear specimens in both groups had detectable levels of IL-22, whereas IL-6 and IL-17E showed very low frequencies of positivity. The one control with a positive sample for IL-6 was not the same control that was the only control sample positive for IL-17E. There was no difference between the CXCL2 levels for cases and controls with more than 75% of tear specimens yielding detectable quantities of this molecule (cases 56/67, 84% and controls, 10/13, 77%).
Figures 2-5 show the concentrations of IL-6, IL-8, IL-22, and IL-17E, respectively, in tears of individual cases (by visit) and individual controls that measured above detectable limits by the Luminex. Figure 6 shows the concentration of CXCL2 in tears of individual cases (by visit) and individual controls that measured above detectable limits by ELISA. There was no difference between the median concentration of IL-8, IL-22, and CXCL2 in tears of cases and controls (z = 20.57, z = 0.97 and Z = 0.05, respectively). Only 1 control sample was positive for IL-6 and IL-17E, and so the Mann-Whitney U test could not be performed. Figure 7 shows the proportions of detectable protein samples (IL-8, IL-22, IL-6, and IL-17E) investigated with the Luminex for severe cases compared with mild-moderate cases. IL-22 was less likely to be detected among the mildmoderate cases compared with the severe cases of AK (P = 0.02); however, there was no difference between mildmoderate cases and severe cases for the proteins, IL-8, IL-6, and IL-17E (P = 0.48, P = 0.27, and P = 1, respectively). There was also no difference in CXCL2 levels between the severe and moderate/mild cases (23/29, 79.3% compared with 33/38, 86.8%, P = 0.41). Table 3 shows the median tear protein concentrations for severe samples compared with the mild-moderate samples. There was a higher level of IL-8 detectable in the tears of severe cases compared with the mild-moderate cases of this infection (z = 22.31); however, there was no difference between tear protein levels of IL-22, IL-6, IL-17E, and CXCL2).
Severe Versus Mild-Moderate Cases

DISCUSSION
This study was the first to examine the cytokine levels in patients with mild AK compared with more severe AK and compare these with the cytokine levels of control CL wearers. This study has highlighted IL-8 as a key molecule in the AK inflammatory response, and there is also some evidence for cell-mediated inflammatory response involving the IL-17 pathway through IL-22. IL-8 was found to be expressed at a detectable level measured by the Luminex more often in cases of AK than in control CL wearers and in higher concentrations in more severe cases than in milder forms of the disease. IL-8 is a key inflammatory chemokine that mobilizes and activates neutrophils. 7 Neutrophils are essential components of the early inflammatory response to Acanthamoeba. 8 Furthermore, IL-8 is part of the Toll-like receptor 4 cascade, which initiates the cytokine response in AK. 9 IL-8 also promotes angiogenesis in the eye, 7 and further characterization of patients who develop neovascularization in AK may reveal differences in levels that may predict patients who continue to develop this complication, and more targeted management such as frequent topical steroids may be advocated in these cases. Neovascularization is contraindicated in corneal transplant candidates, often the last resort to significantly improve vision in patients with AK. Keratoplasty is required for visual rehabilitation in around 12% of AK cases. 2 IL-22, part of the IL-10 family, and a proinflammatory Th17 cytokine, 10 was detected more often in severe cases than in milder forms of AK. IL-22 may prolong the inflammatory response and, in severe forms of disease, this may be beneficial to control infection but may also be involved in tissue destruction due to inflammation.
Most of the IL-17 cytokines were not detected in levels high enough to be measured in the tears in these subjects using Luminex technology. Because multiplex bead arrays are well established as being one of the more sensitive methods of detection for low levels of analytes, the specimens with no detectable levels were presumed negative. It may be useful to compare the IL-17E cytokine, which was expressed by a small number of cases and 1 control, using ELISA, in another cohort of samples. Like IL-22, IL-17 has been implicated in chronic inflammatory conditions, 11 and IL-17A has recently been shown to be protective against AK severity in a mouse model. 12 This contrasts with keratitis caused by herpes simplex virus and Pseudomonas, in which IL-17A is associated with an increased corneal inflammatory response. [13] [14] [15] IL-17A is known as a "double sword" agent; in some circumstances, it protects the host and in others it results in chronic inflammation and tissue damage. 16 IL-17A both initiates and activates neutrophils and is also produced by neutrophils. 17 Recently, a novel population of neutrophils was characterized, that are capable of autocrine IL-17A activity, which leads to increased death of fungal hyphae in a murine model of Aspergillus corneal infection. 18 FIGURE 3. IL-8 protein levels above the minimum detectable limit for individual cases (by visit) and individual controls measured by the Luminex. CXCL2 (also known as macrophage inflammatory protein 2-alpha) seems to be constitutively expressed in AK cases and control CL wearers and not upregulated or downregulated in this disease. Macrophage inflammatory protein 2 has been shown to be important in animal models of AK. 19 Animal models of disease do not exhibit the severe inflammatory complications of AK, such as scleritis, 5 and inflammatory pathways may vary somewhat between humans and animal models.
IL-6, a proinflammatory cytokine with several functions, was only detected in 1 control sample; either this study did not have enough power to show differences between cases and controls or IL-6 is not important in the inflammatory response in this disease. Furthermore, it is possible that there is a defect in IL-6 at the protein level. Our group has found that single-nucleotide polymorphisms of IL-6 genes are implicated in the susceptibility and severity of bacterial keratitis in CL wearers. 20 IL-6 is a key player in the IL-22 and IL-17 pathways, 11 and it would be prudent to further investigate this protein as a candidate in future immunological analysis in AK.
Cytokine and chemokine profiles correlate with several inflammatory anterior eye disease states such as dry eye, [21] [22] [23] [24] allergic eye disease, 25, 26 autoimmune conditions, Sjogren syndrome, [27] [28] [29] vernal keratoconjunctivitis, 30 and ocular rosacea. 31 Two studies have highlighted tear protein profiles associated with bacterial 32 and fungal keratitis. 33 In bacterial keratitis, cytokines and chemokines are upregulated in both affected and contralateral eyes, and these changes have been correlated with cellular changes imaged on the ocular surface. 32 Specifically, IL-1b, IL-6, and IL-8 were elevated in the "infected" tears compared with tears of nonaffected controls. Changes were also found in the contralateral eye of patients with bacterial keratitis, namely upregulation of chemokine ligand 2 (CCL-2), IL-10, and IL17a. Triggering Receptor Expressed On Myeloid Cells 1 (TREM-1) was also elevated in both affected and contralateral eyes. Changes in tear cytokines were correlated with dendritic cell and subbasal nerve fiber presence and morphology, as follows; tear concentrations of the proinflammatory cytokines, IL-1B, IL-6, IL-8, and IL-17a were positively correlated with dendritic cell density, and IL-1B, IL-6, IL-8, and TREM-1 were inversely correlated with subbasal nerve density.
Proteomic analyses have been used in an Indian study of patients with fungal keratitis compared with controls to examine differences between tear proteins. Seven protein levels varied between the cases and controls: prolactininducible protein and serum albumin precursor were upregulated in the infected samples; cystatin S precursor, cystatin SN precursor, cystatin, and human tear lipocalin were downregulated in the infected samples; glutaredoxin-related protein was found only in the infected samples. 33 Concentrations of the following cytokines for all subjects in this study fell below the detectable limit for IFNg, IL-10, IL-1b, IL-27, as well as IL-17F and IL-17A. Cross-reactivity of the antibodies and/or poor sensitivity of the array are unlikely to be implicated because bead-based Luminex technology is one of the most sensitive assays available and has successfully allowed detection of cytokines in tear fluids. 34 It is possible that these cytokines were masked from detection FIGURE 5. IL-17E protein levels above the minimum detectable limit for individual cases (by visit) and individual controls as measured by the Luminex. FIGURE 6. CXCL2 protein levels above the minimum detectable limit for individual cases (by visit) and individual controls measured by the ELISA.
in the tear specimens because of build-up of protein and debris at the ocular surface. Alternatively, these cytokines might not be involved in this disease but, until a larger cohort of specimens and controls is investigated, this cannot be assumed.
The differences in cytokine levels found in this study may be due to the effects of the disease on the immune system and/or due to differences in the individual's immune profile at the gene level. Being such a rare disease, it is impossible to conduct a prospective study and compare cytokine levels before and during AK disease; however, future studies that assess variations in the DNA structure of these genes in patients will provide more insight into this conundrum. Furthermore, the differences between mild/moderate and severe disease may be due to differences in strains of acanthamoeba. Most Acanthamoeba spp. that cause keratitis are from the T4 group based on 18S rRNA genotyping, which separates strains into 17 evolutionary clades or groups (T1-T17). Preliminary information from one study indicates that strains with non-T4 genotypes may cause more severe disease; 35 however, only 3 cases of non-T4 AK were compared with 14 T4 genotypes and confirmation in a larger study is required. Because genetic profiling of Acanthamoeba spp. allows more refined typing, as can be seen by mitochondrial cytochrome oxidase (cox) gene sequencing, 36 and a greater number of cases are reported from other T strains, 37, 38 correlation between different strains and the outcomes of AK may be found. Human biomarker profiling alongside in vitro and animal models will be key to future understanding of the interplay between the host immune system and organism virulence that is evidenced in some conditions such as malaria. 39 A limitation of this study could be that AK cases were younger than controls. Tear investigations have generally been limited to normals or certain conditions affecting specific age groups, and differences between normals across a range of ages have not been shown. Dry eye is more prevalent in older individuals, and increased levels of 2 cytokines measured in this study, IL-6 and IL-8 have been found in elevated levels in patients with dry eye. [21] [22] [23] [24] The controls in this study, although older than the cases, were successful CL wearers and are unlikely to have had significant dry eye disease. In any case, had some of the cases been on the dry eye spectrum, this would have only potentially masked greater differences in IL-8 levels and would not have affected the IL-6 results, in which only 1 control showed a reading above the detectable level.
Daily disposable CL wearers were more in the control group than in patients with AK in this study. This likely reflects the evidence that AK is more often a disease that occurs in reusable lens wearers, as environmental contamination of lens cases supports the growth of Acanthamoeba spp. 40 Only 1 study has evaluated the tear profile while wearing different lens types; using lotrafilcon B (O2OPTIX; CIBA VISION, Duluth, Atlanta, GA) or senofilcon A (Acuvue Oasys; Johnson & Johnson Vision Care, Inc, Jacksonville, FL), no differences in levels of matrix metalloproteinase 9 (MMP-9), tissue inhibitor of metalloproteinases 1 (TIMP-1), and neutrophil gelatinase-associated lipocalin (NGAL) during adapted daily wear were found. 41 It is unlikely that even if the lens wear type had an effect on tear cytokine/chemokine levels that this would confound results of this study as all the patients with AK and a proportion of the controls were not wearing lenses at the time of collection. Another limitation of the study might be the time of the collection of tear samples. The tear collection time was scheduled between 10 AM and 4 PM to minimize possible diurnal effects and disruption to the Moorfields Eye Hospital and IO clinics. Although there are recent publications showing a diurnal change of certain tear cytokines and chemokines, they indicate a difference between daytime and evening intervals (11 AM-1 PM vs. 5-7 PM) 42 ; 12 AM (midday) compared with 9 to 12 PM (midnight). 43 It is improbable that there would be a major variation in cytokine and chemokine levels during the 6-hour daytime interval in which we sampled tears.
This study highlights key areas for future investigation of the pathogenesis of AK. We have shown that in a clinical setting, we can collect tears from patients with AK that may indicate the inflammatory status of the eye. Further investigation of cytokines not detected in this study, and other candidates in the pathways indicated by this analysis, may define a wider spectrum of cytokine changes. In association with careful tracking of patients during the disease process, we may be able to predict when the inflammatory status is changing. This information may help the clinician to better understand the clinical picture and make more informed decisions on management of individual patients with AK.
